EP Patent

EP1894568A1 — Pharmaceutical compositions for the treatment of inflammatory or obstructive airway diseases

Assigned to Novartis AG · Expires 2008-03-05 · 18y expired

What this patent protects

Medicaments comprising (A) an antimuscarinic agent, (B) a beta-2 adrenoreceptor agonist and (C) a corticosteroid for the treatment of inflammatory or obstructive airways diseases.

USPTO Abstract

Medicaments comprising (A) an antimuscarinic agent, (B) a beta-2 adrenoreceptor agonist and (C) a corticosteroid for the treatment of inflammatory or obstructive airways diseases.

Drugs covered by this patent

glycopyrronium-tosylate (GLYCOPYRRONIUM TOSYLATE)

Patent Metadata

Patent number: EP1894568A1
Jurisdiction: EP
Classification: —
Expires: 2008-03-05
Drug substance claim: No
Drug product claim: No
Assignee: Novartis AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.